These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recombinant human growth hormone as potential therapy for osteoporosis. Marcus R Baillieres Clin Endocrinol Metab; 1998 Jul; 12(2):251-60. PubMed ID: 10083895 [TBL] [Abstract][Full Text] [Related]
10. Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Lindsey RC; Mohan S Mol Cell Endocrinol; 2016 Sep; 432():44-55. PubMed ID: 26408965 [TBL] [Abstract][Full Text] [Related]
11. [Male osteoporosis: current treatments and future options]. Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284 [TBL] [Abstract][Full Text] [Related]
12. Research on growth hormone (GH) and the insulin-like growth factors (IGFs). Le Roith D; Sonksen PH Growth Horm IGF Res; 1998 Feb; 8(1):1-2. PubMed ID: 10990438 [No Abstract] [Full Text] [Related]
13. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited? Rosen CJ J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328 [TBL] [Abstract][Full Text] [Related]
14. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Marie PJ; Kassem M Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Zofková I Physiol Res; 2003; 52(6):657-79. PubMed ID: 14640888 [TBL] [Abstract][Full Text] [Related]
16. [Anabolic therapy of osteoporosis]. Fernández-García D; Alonso G; Muñoz-Torres M Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635 [TBL] [Abstract][Full Text] [Related]
17. Bone metabolism in relation to alterations in systemic growth hormone. Ueland T Growth Horm IGF Res; 2004 Dec; 14(6):404-17. PubMed ID: 15519248 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone, insulin-like growth factors and bone remodelling. Eriksen EF; Kassem M; Langdahl B Eur J Clin Invest; 1996 Jul; 26(7):525-34. PubMed ID: 8864413 [No Abstract] [Full Text] [Related]
19. Somatopause: dismetabolic and bone effects. Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721 [TBL] [Abstract][Full Text] [Related]